| Ident. | Authors (with country if any) | Title |
|---|
| 000052 (2020) |
Joëlle Micallef [France] ; Thomas Soeiro [France] ; Annie-Pierre Jonville-Béra [France] | Non-steroidal anti-inflammatory drugs, pharmacology, and COVID-19 infection. |
| 000349 (2020) |
J-M Michot [France] ; L. Albiges ; N. Chaput ; V. Saada ; F. Pommeret ; F. Griscelli ; C. Balleyguier ; B. Besse ; A. Marabelle ; F. Netzer [France] ; M. Merad ; C. Robert ; F. Barlesi ; B. Gachot [France] ; A. Stoclin [France] | Tocilizumab, an anti-IL-6 receptor antibody, to treat COVID-19-related respiratory failure: a case report. |
| 000424 (2020) |
Solomon Hsiang [États-Unis, Royaume-Uni] ; Daniel Allen [États-Unis] ; Sébastien Annan-Phan [États-Unis] ; Kendon Bell [États-Unis, Nouvelle-Zélande] ; Ian Bolliger [États-Unis] ; Trinetta Chong [États-Unis] ; Hannah Druckenmiller [États-Unis] ; Luna Yue Huang [États-Unis] ; Andrew Hultgren [États-Unis] ; Emma Krasovich [États-Unis] ; Peiley Lau [États-Unis] ; Jaecheol Lee [États-Unis] ; Esther Rolf [États-Unis] ; Jeanette Tseng [États-Unis] ; Tiffany Wu [États-Unis] | The effect of large-scale anti-contagion policies on the COVID-19 pandemic. |
| 000444 (2020) |
Benjamin Pradère [France] ; Guillaume Ploussard [France] ; James W F. Catto [Royaume-Uni] ; Morgan Rouprêt [France] ; Vincent Misrai [France] | The Use of Nonsteroidal Anti-inflammatory Drugs in Urological Practice in the COVID-19 Era: Is "Safe Better than Sorry"? |
| 000514 (2020) |
Bruno Bonaz [France] ; Valérie Sinniger [France] ; Sonia Pellissier [France] | Targeting the cholinergic anti-inflammatory pathway with vagus nerve stimulation in patients with Covid-19? |
| 000605 (2020) |
Margherita Giannini [France] ; Mickael Ohana [France] ; Benoit Nespola [France] ; Giovanni Zanframundo [Italie] ; Bernard Geny [France] ; Alain Meyer [France] | Similarities between COVID-19 and anti-MDA5 syndrome: what can we learn for better care? |
| 000607 (2020) |
Yvan Jamilloux [France] ; Thomas Henry [France] ; Alexandre Belot [France] ; Sébastien Viel [France] ; Maxime Fauter [France] ; Thomas El Jammal [France] ; Thierry Walzer [France] ; Bruno François [France] ; Pascal Sève [France] | Should we stimulate or suppress immune responses in COVID-19? Cytokine and anti-cytokine interventions. |
| 000734 (2020) |
Alexis Mathian [France] ; Marc Pineton De Chambrun [France] ; Alain Combes [France] ; Zahir Amoura [France] | Response to: 'Presence of anti-phospholipid antibodies in COVID-19: a case series study' by Amezcua-Guerra et al. |
| 000951 (2020) |
Markus Zeitlinger [Autriche] ; Birgit C P. Koch [Pays-Bas] ; Roger Bruggemann [Pays-Bas] ; Pieter De Cock [Belgique] ; Timothy Felton [Royaume-Uni] ; Maya Hites [Belgique] ; Jennifer Le [États-Unis] ; Sonia Luque [Espagne] ; Alasdair P. Macgowan [Royaume-Uni] ; Deborah J E. Marriott [Australie] ; Anouk E. Muller [Pays-Bas] ; Kristina Nadrah [Slovénie] ; David L. Paterson [Australie] ; Joseph F. Standing [Royaume-Uni] ; João P. Telles [Brésil] ; Michael Wölfl-Duchek [Autriche] ; Michael Thy [France] ; Jason A. Roberts [Australie, France] | Pharmacokinetics/Pharmacodynamics of Antiviral Agents Used to Treat SARS-CoV-2 and Their Potential Interaction with Drugs and Other Supportive Measures: A Comprehensive Review by the PK/PD of Anti-Infectives Study Group of the European Society of Antimicrobial Agents. |
| 000D32 (2020) |
Benjamin Davido [France] ; Ghilas Boussaid [France] ; Isabelle Vaugier [France] ; Thibaud Lansaman [France] ; Frédérique Bouchand [France] ; Christine Lawrence [France] ; Jean-Claude Alvarez [France] ; Pierre Moine [France] ; Véronique Perronne [France] ; Frédéric Barbot [France] ; Azzam Saleh-Mghir [France] ; Christian Perronne [France] ; Djillali Annane [France] ; Pierre De Truchis [France] | Impact of medical care, including use of anti-infective agents, on prognosis of COVID-19 hospitalized patients over time. |
| 000D63 (2020) |
Jaume Alijotas-Reig [Espagne] ; Enrique Esteve-Valverde [Espagne] ; Cristina Belizna [France] ; Albert Selva-O'Callaghan [Espagne] ; Josep Pardos-Gea [Espagne] ; Angela Quintana [Espagne] ; Arsene Mekinian [France] ; Ariadna Anunciacion-Llunell [Espagne] ; Francesc Mir Mur [Espagne] | Immunomodulatory therapy for the management of severe COVID-19. Beyond the anti-viral therapy: A comprehensive review. |
| 000D64 (2020) |
Bernadette Van Den Hoogen [Pays-Bas] ; Angela Santoni [Italie] ; Giuseppe Sciumé [Italie] ; Andrew Bowie [Irlande (pays)] ; Cliona O'Farrelly [Irlande (pays)] ; Luke O'Neill [Irlande (pays)] ; Marit Anthonsen [Norvège] ; Katerina Pardali [Suède] ; Simon Young [Suède] ; Andreas Bergthaler [Autriche] ; Nicolas Manel [France] ; Roland Zahn [Pays-Bas] ; Marjolein Kikkert [Pays-Bas] ; Eric Snijder [Pays-Bas] ; Frank Van Kuppeveld [Pays-Bas] ; Ron Fouchier [Pays-Bas] ; John Hiscott [Italie] | Immunometabolism pathways as the basis for innovative anti-viral strategies (INITIATE): A Marie Sklodowska-Curie innovative training network. |
| 000E39 (2020) |
Narjis Boukli [France] ; Melchior Le Mene [France] ; Aurélie Schnuriger [France] ; Nancy Stella Cuervo [France] ; Cécilia Laroche [France] ; Laurence Morand-Joubert [France] ; Joël Gozlan [France] | High incidence of false positive results in patients with other acute infections, using the LIAISON® SARS-CoV-2 commercial chemiluminescent micro-particle immunoassay for detection of IgG anti SARS-CoV-2 antibodies. |
| 000E62 (2020) |
Adrien Breiman [France] ; Nathalie Ruvën-Clouet [France] ; Jacques Le Pendu [France] | Harnessing the natural anti-glycan immune response to limit the transmission of enveloped viruses such as SARS-CoV-2. |
| 000E82 (2020) |
Jean-François Korobelnik [France] ; Anat Loewenstein [Israël] ; Bora Eldem [Turquie] ; Antonia M. Joussen [Allemagne] ; Adrian Koh [Singapour] ; George N. Lambrou [Suisse] ; Paolo Lanzetta [Italie] ; Xiaoxin Li [République populaire de Chine] ; Monica Lövestam-Adrian [Suède] ; Rafael Navarro [Espagne] ; Annabelle A. Okada [Japon] ; Ian Pearce [Royaume-Uni] ; Francisco J. Rodríguez [Colombie] ; David T. Wong [Canada] ; Lihteh Wu [Costa Rica] | Guidance for anti-VEGF intravitreal injections during the COVID-19 pandemic. |
| 001079 (2020) |
Naceur Essid [Tunisie] ; Mohamed Allouche [Tunisie] ; Mounira Lazzem [Tunisie] ; Abdel Halim Harrath [Arabie saoudite] ; Lamjed Mansour [Arabie saoudite] ; Saleh Alwasel [Arabie saoudite] ; Ezzeddine Mahmoudi [Tunisie] ; Hamouda Beyrem [Tunisie] ; Fehmi Boufahja [Tunisie] | Ecotoxic response of nematodes to ivermectin, a potential anti-COVID-19 drug treatment. |
| 001103 (2020) |
Baptiste Demey [France] ; Nagib Daher ; Catherine François [France] ; Jean-Philippe Lanoix ; Gilles Duverlie [France] ; Sandrine Castelain [France] ; Etienne Brochot [France] | Dynamic profile for the detection of anti-SARS-CoV-2 antibodies using four immunochromatographic assays. |
| 001203 (2020) |
Roch Houot [États-Unis] ; Ronald Levy [États-Unis] ; Guillaume Cartron [France] ; Philippe Armand [États-Unis] | Could anti-CD20 therapy jeopardise the efficacy of a SARS-CoV-2 vaccine? |
| 001599 (2020) |
Giuseppe Di Lorenzo [Italie] ; Rossella Di Trolio [Italie] ; Zisis Kozlakidis [France] ; Giuseppina Busto [Italie] ; Concetta Ingenito [Italie] ; Luciana Buonerba [Italie] ; Claudia Ferrara [Italie] ; Annamaria Libroia [Italie] ; Gianluca Ragone [Italie] ; Concetta Dello Ioio [Italie] ; Beatrice Savastano [Italie] ; Mario Polverino [Italie] ; Ferdinando De Falco [Italie] ; Simona Iaccarino [Italie] ; Emilio Leo [Italie] | COVID 19 therapies and anti-cancer drugs: A systematic review of recent literature. |
| 001624 (2020) |
Elisabeth Maillart [France] ; Caroline Papeix [France] ; Catherine Lubetzki [France] ; Thomas Roux [France] ; Valérie Pourcher [France] ; Céline Louapre [France] | Beyond COVID-19: DO MS/NMO-SD patients treated with anti-CD20 therapies develop SARS-CoV2 antibodies? |
| 001625 (2020) |
Vincent Gies [France] ; Nassima Bekaddour [France] ; Yannick Dieudonné [France] ; Aurélien Guffroy [France] ; Quentin Frenger [France] ; Frédéric Gros [France] ; Mathieu Paul Rodero [France] ; Jean-Philippe Herbeuval [France] ; Anne-Sophie Korganow [France] | Beyond Anti-viral Effects of Chloroquine/Hydroxychloroquine. |
